[BGLC] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
15-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 953.57%
YoY- 26.07%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 2,485 3,029 3,245 3,576 3,092 3,449 11,360 -63.79%
PBT -140 31 197 370 137 339 1,435 -
Tax -2 14 108 75 108 0 167 -
NP -139 17 89 295 28 339 1,269 -
Tax Rate - -45.59% -54.72% -20.29% -79.30% 0.00% -11.61% -
Total Cost 2,624 3,012 3,156 3,281 3,064 3,110 10,092 -59.36%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -5.58 0.56 2.75 8.26 0.91 9.82 11.17 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.01 0.00 0.01 0.02 0.00 0.02 -0.02 -37.08%
EPS Diluted -0.01 0.00 0.01 0.02 0.00 0.02 -0.02 -37.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.